Showing 1 - 10 of 50
Persistent link: https://www.econbiz.de/10010247809
Persistent link: https://www.econbiz.de/10011531129
Persistent link: https://www.econbiz.de/10011500056
Persistent link: https://www.econbiz.de/10011500083
Persistent link: https://www.econbiz.de/10011384131
We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...
Persistent link: https://www.econbiz.de/10012295656
Persistent link: https://www.econbiz.de/10011690739
Persistent link: https://www.econbiz.de/10011808123
Persistent link: https://www.econbiz.de/10011755798
The paper focuses on two control instruments created by the Italian Companies and Exchange Commission (CONSOB), the Blacklist and the Grey-list, to monitor the going-concern perspectives of listed Italian companies in distress situations. The study analyzes the determinants underlying the...
Persistent link: https://www.econbiz.de/10012210804